The Endowment: Each School’s Stake

(Sidebar) The shrinking Harvard endowment affects the University's different schools differently.

Return to main article:

Harvard’s endowment, valued at $36.9 billion as of last June 30, in fact belongs to the separate schools and other academic departments. The large chart shows the share of the endowment owned by each (the Faculty of Arts and Sciences loomed largest, at $15.7 billion—nearly 43 percent of the total). Of crucial importance is each school’s dependence on distributions from the endowment for its operating budget, shown in the inset chart. Source: Harvard University Financial Report, Fiscal Year 2008.

Chart by Stephen Anderson

You might also like

Harvard Funds Student “Bridges” Projects

Eight new initiatives to build community on campus will get underway early next year. 

Harvard Symposium Tackles 400 Years of Homelessness in America

Professors explore the history of homelessness in the U.S., from colonial poor laws to today’s housing crisis

Harvard Alumni Affairs Databases Breached

The University is investigating the cyberattack, which may have compromised the personal information of alumni, donors, students, faculty, and staff.

Most popular

Harvard Faculty Discuss Tenure Denials

New data show a shift in when, in the process, rejections occur

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

Explore More From Current Issue

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.